Dr. Alexander Ghobadimanesh, D.O. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 30211 Avenida De Las Bandera Ste 200, Rancho Santa Margarita, CA 92688 Phone: 949-490-6362 Fax: 650-590-4938 |
Dr. Kasra Maasumi, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 30212 Tomas Ste 180, Rancho Santa Margarita, CA 92688 Phone: 949-599-7400 Fax: 949-599-1430 |
News Archive
Roll Call reports that Senate Republican Leader Mitch McConnell Tuesday "appeared to concede that there was little Republicans could do to block passage of health care reform" but said he hopes Democrats change their course on the reform bill.
The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
The high levels of caffeine in energy drinks may lead to cardiac complications, suggests a case report in the July/August Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine. The journal is published by Wolters Kluwer.
Regeneron Pharmaceuticals, Inc. today announced that in the Phase 3 VIVID-DME trial of EYLEA® (aflibercept) Injection for the treatment of diabetic macular edema (DME), EYLEA 2 milligrams (mg) dosed monthly (2Q4) and EYLEA 2 mg dosed every two months (after 5 initial monthly injections, 2Q8) showed a sustained improvement from baseline in best corrected visual acuity (BCVA) at week 100 (2 years), compared to laser photocoagulation.
› Verified 6 days ago